Methadone Clinics Lift 3-Month Retention 17% After 2024 Rule Overhaul

1 articles · Updated · STAT · Aug 14

A survey of 241 opioid treatment programs found average three-month retention rose 17% after clinics expanded take-home methadone and eased other rules under the 2024 federal overhaul.
More than 75% of programs provided more take-home medication, according to industry group AATOD, while over 70% of respondents adopted at least half of SAMHSA’s recommended practice changes.
Those changes made counseling optional rather than a condition for medication, treated drug tests as one clinical factor instead of an automatic punishment, and scrapped admission rules requiring a year of addiction or two failed prior treatments.
State oversight is shifting more slowly: roughly two-thirds of state opioid treatment authorities adopted the counseling change, and critics said the survey covered just over 10% of clinics and may overstate uptake, especially outside more progressive states.
The overhaul capped a shift that began with pandemic-era take-home flexibilities, testing whether methadone treatment can move away from daily in-person dosing and more punitive clinic culture.